ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,2,Linear IgA disease,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
5,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
5,4,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
7,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
7,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
9,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
12,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
14,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
15,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
17,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
19,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
20,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
21,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
23,1,Conjunctival irritation,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
24,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
24,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
26,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
27,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
28,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
29,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
29,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
29,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
29,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
29,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
30,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
30,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
31,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
31,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
32,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,Y
33,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
34,1,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,Y
34,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
35,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
36,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
36,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Anterior chamber disorder,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
38,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
39,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
40,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
41,1,Lip infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
41,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
42,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
42,2,Guthrie test positive,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
42,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
43,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
44,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
45,1,Disorder of orbit,Ocular disorders NEC,Eye disorders NEC,Eye,N
46,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
46,2,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
46,3,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
46,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
46,5,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
46,6,Parophthalmia,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
46,7,Parophthalmia,"Orbital infections, inflammations and irritations","Ocular infections, irritations and inflammations",Eye,N
46,8,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
47,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
47,2,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
47,3,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
48,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
49,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
49,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
50,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
51,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
52,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
53,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
54,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
55,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
56,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
57,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
58,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
59,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
59,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
60,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
61,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
61,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
61,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
61,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
62,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
62,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
62,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
64,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
65,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
66,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
66,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
67,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
67,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
67,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
68,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
70,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
70,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
70,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
71,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
72,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
73,1,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
74,1,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
75,1,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
76,1,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
77,1,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
78,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
78,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
78,3,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
79,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
80,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
80,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
80,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
80,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
80,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
81,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
81,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
81,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,4,Wound sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
82,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
83,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
85,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
86,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
87,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
87,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
88,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
88,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
89,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
89,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
90,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
90,2,Suspected transmission of an infectious agent via product,Infectious transmissions,Ancillary infectious topics,Infec,N
91,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
91,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
91,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
92,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
92,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
92,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,4,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
92,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
92,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
92,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,9,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
93,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
94,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
94,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
95,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
95,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
95,4,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
96,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
97,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,1,Acinetobacter infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
98,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
99,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
99,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
100,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
101,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
101,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
102,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
104,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
105,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
105,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
105,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
105,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
105,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
106,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
107,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
109,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
109,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
110,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
110,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
111,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
111,2,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
112,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
112,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
113,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
113,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
113,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
114,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
115,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
116,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
117,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
118,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
119,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
120,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
120,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
120,3,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
120,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
120,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
121,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
122,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
123,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
124,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
124,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
124,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
124,5,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
125,1,Anaphylactoid shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
126,1,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
127,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
127,2,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
128,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
129,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
129,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
130,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
131,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
132,1,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
132,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
133,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
134,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
135,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
